“…As seen in the results of the analysis presented above, the number of adverse events reported to the FDA (US) grew at an average annual rate of 15.8% for the 2013 to 2018 period. This growth rate is lower than the 22.1% per annum observed for the 2007 to 2012 period [16]; which may be indicating that the rate of reporting may have, on the whole, slowed down during the 2013 to 2018 period, compared to that of the 2007 to 2012 period. It could also be that in LAERS, the system did not recognise some of the duplicate reports as such, passing them off It is worth noting that more reports were received for the 2013 to 2018 period than for the 2007 to 2012 period [16] as the total number of reports (6,714,463) received for the 2013 to 2018 period is approximately 2.7 times the number of reports (2,483,936) The rate of growth of the number of death which appeared to be increasing in the 2007 to 2012 period seem to have stabilized as the proportion of deaths relative to both the overall number of reports and the non-missing cases seem to hover around 9% and 17% respectively (Figure 3).…”